105 related articles for article (PubMed ID: 25672722)
1. [Recent findings in dermatomyositis-specific autoantibodies].
Fujimoto M
Rinsho Shinkeigaku; 2014; 54(12):1110-2. PubMed ID: 25672722
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in dermatomyositis-specific autoantibodies.
Fujimoto M; Watanabe R; Ishitsuka Y; Okiyama N
Curr Opin Rheumatol; 2016 Nov; 28(6):636-44. PubMed ID: 27533321
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
Muro Y; Ishikawa A; Sugiura K; Akiyama M
Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of autoantibodies for the diagnosis of autoimmune myopathies].
Allenbach Y; Benveniste O
Rev Neurol (Paris); 2013; 169(8-9):656-62. PubMed ID: 23642286
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients].
Bodoki L; Budai D; Nagy-Vincze M; Griger Z; Betteridge Z; Dankó K
Orv Hetil; 2015 Sep; 156(36):1451-9. PubMed ID: 26320599
[TBL] [Abstract][Full Text] [Related]
6. [Dermatomyositis-specific antibodies].
Bodoki L; Nagy-Vincze M; Griger Z; Dankó K
Z Rheumatol; 2015 May; 74(4):363-9. PubMed ID: 25644067
[TBL] [Abstract][Full Text] [Related]
7. Distinct clinical and histological features in dermatomyositis with anti-aminoacyl-tRNA synthetase antibodies.
Ishibuchi H; Motegi S; Kishi C; Amano H; Ishikawa O
J Dermatol; 2016 Aug; 43(8):978-80. PubMed ID: 26919552
[No Abstract] [Full Text] [Related]
8. [Dermatomyositis].
Fujimoto M
Brain Nerve; 2023 Jul; 75(7):847-854. PubMed ID: 37431075
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis/polymyositis and interstitial lung disease.
Hane H; Muro Y; Watanabe K; Ogawa Y; Sugiura K; Akiyama M
Clin Chim Acta; 2014 Apr; 431():9-14. PubMed ID: 24508626
[TBL] [Abstract][Full Text] [Related]
10. Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.
Wolstencroft PW; Fiorentino DF
Curr Rheumatol Rep; 2018 Apr; 20(5):28. PubMed ID: 29637414
[TBL] [Abstract][Full Text] [Related]
11. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study.
Fujikawa K; Kawakami A; Kaji K; Fujimoto M; Kawashiri S; Iwamoto N; Aramaki T; Ichinose K; Tamai M; Kamachi M; Nakamura H; Ida H; Origuchi T; Ishimoto H; Mukae H; Kuwana M; Kohno S; Takehara K; Sato S; Eguchi K
Scand J Rheumatol; 2009; 38(4):263-7. PubMed ID: 19444719
[TBL] [Abstract][Full Text] [Related]
12. [Anti-PL-7, anti-PL-12, and other anti-aminoacyl tRNA synthetase antibodies].
Hirakata M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():555-9. PubMed ID: 20942128
[No Abstract] [Full Text] [Related]
13. [Anti-MI-2 antibody as a specific marker of dermatomyositis].
Kowalska-Oledzka E; Jarzabek-Chorzelska M; Kołacińska-Strasz Z
Neurol Neurochir Pol; 1995; 29(5):703-11; discussion 712. PubMed ID: 8584096
[TBL] [Abstract][Full Text] [Related]
14. [Myositis-specific autoantibodies and their clinical significance].
Suzuki S
Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472
[TBL] [Abstract][Full Text] [Related]
15. [Myositis-specific autoantibodies].
Fujimoto M
Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
[TBL] [Abstract][Full Text] [Related]
16. Immune manifestations of inflammatory muscle disease.
Targoff IN
Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
Mimori T; Imura Y; Nakashima R; Yoshifuji H
Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
[TBL] [Abstract][Full Text] [Related]
18. [Laboratory diagnostics of polymyositis/dermatomyositis].
Prus V; Bedeković D
Reumatizam; 2012; 59(2):27-30. PubMed ID: 23745451
[TBL] [Abstract][Full Text] [Related]
19. [Interstitial lung disease in patients with connective tissue diseases].
Hirakata M; Nakamura K; Kaburaki J; Suwa A; Mimori T; Kanazawa M; Akizuki M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():268-76. PubMed ID: 8752518
[TBL] [Abstract][Full Text] [Related]
20. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
